ENTA
Closed
Enanta Pharmaceuticals Inc
7.7
+0.1 (+1.32%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 7.56
Day's Range: 7.51 - 7.825
Send
sign up or login to leave a comment!
When Written:
40.44
Enanta Pharmaceuticals Inc. is a biotechnology company that develops small molecule drugs for the treatment of viral infections and liver diseases. The company was founded in 1995 and is headquartered in Watertown, Massachusetts. Enanta's lead product is a hepatitis C virus protease inhibitor called paritaprevir, which is marketed by AbbVie under the brand name Holkira Pak. The company also has a pipeline of other antiviral and liver disease drugs in various stages of development. Enanta has partnerships with several pharmaceutical companies, including AbbVie, Novartis, and GlaxoSmithKline. The company went public in 2013 and is traded on the NASDAQ under the symbol ENTA.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








